Cerebrolysin
Also known as: FPE 1070
Primary recreational use: Cognitive recovery and enhancement
What is Cerebrolysin?
Cerebrolysin is a standardized neuropeptide preparation derived from purified porcine brain proteins, designed to support neurological recovery. It's primarily used for stroke recovery, traumatic brain injury, and cognitive enhancement. While approved in over 40 countries for these conditions, it is not FDA approved in the United States. Key concerns include mixed clinical trial results and the potential for mild side effects.
Primary Benefits
Enhances cognitive function. Promotes neurological recovery. Protects neurons from excitotoxic damage.
How It Works
Cerebrolysin contains neurotrophic factors that mimic BDNF, NGF, and CNTF activity. It enhances neuroplasticity, protects neurons from excitotoxicity, promotes neurogenesis, and improves synaptic function by engaging pathways such as PI3K/AKT and Sonic hedgehog, ultimately supporting neuronal recovery and protection.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T use if you have epilepsy or severe renal insufficiency.
- 2.NEVER freeze Cerebrolysin as it damages the peptide structure.
- 3.DON'T mix with amino acid solutions or cardiovascular medications.
- 4.AVOID using in case of known hypersensitivity to any components.
- 5.DON'T administer without ensuring the use of disposable, one-way infusion sets to maintain sterility.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Stroke recovery
strong evidenceUsed to enhance neurological recovery in post-stroke patients by improving neuroplasticity, synaptic function, and cognitive capabilities.
Evidence: Significant clinical evidence supports its use in stroke recovery, with improvements noted in NIHSS and mRS scores. Common dosages include 10-30 mL via IV daily for acute conditions.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Morning
Notes: Administer as soon as possible post-stroke for best results.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Acute stroke recovery | 30 mL | daily | IV infusion |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Anaphylactic shock
Injection-Specific Warnings
- Use sterile technique to prevent infection
Storage
Traumatic brain injury recovery
strong evidenceEmployed to reduce cognitive and motor deficits following TBI, enhancing recovery through neurogenesis and protective mechanisms.
Evidence: Evidence from multiple clinical trials indicates effectiveness in enhancing motor and cognitive recovery post-injury.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Morning
Notes: Start as soon as possible post-trauma.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Early TBI recovery | 50 mL | daily | IV infusion |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Injection-Specific Warnings
- Ensure dilution for large volumes
Storage
Harm Reduction Information
Quality Concerns
- Ensure sourcing from authorized distributors to avoid contamination.
- Product should be clear amber without particles.
- Improper storage can lead to degradation.
Safety Tips
- Use sterile technique and disposable infusion sets.
- Start with lower doses to assess individual response.
- Administer in morning to align with cognitive peak demands.
Warning Signs to Stop
- Severe allergic reaction or anaphylaxis
- Unexplained seizure activity
Seek Medical Help Immediately If
- Symptoms of severe allergic reactions
- Any signs of RTS (repeat treatment syndrome)
Frequently Asked Questions
Common questions about Cerebrolysin
How long until I see effects?
With Cerebrolysin, initial neuroprotective effects may be observed in the first 1-2 weeks, followed by cognitive improvements potentially visible by weeks 3-4.
What time of day should I take it?
Cerebrolysin is best taken in the morning, aligning with peak cognitive demands throughout the day.
How can I minimize side effects?
To minimize side effects with Cerebrolysin, adhere to recommended dosing schedules and consider starting with a lower dose to assess tolerance.
Does tolerance develop?
Cerebrolysin does not typically lead to tolerance as it operates on a neuroprotective rather than a psychoactive basis.
How should I store it?
Store Cerebrolysin at room temperature (≤25°C), protect from light, and never freeze the solution.
Do I need to cycle it?
Cerebrolysin is typically used in treatment cycles, with acute use lasting 10-30 days and chronic conditions requiring cycles of 4 weeks repeated 2-4 times yearly.
Reported Combinations
Compounds reported to be used alongside Cerebrolysin in community discussions
Piracetam
Cognitive enhancement synergy
Donepezil
Shared neuroprotective benefits
Physical therapy
Complementary to rehabilitation efforts
Reported Interactions
Interactions reported in literature and community discussions.
Monitor for cognition enhancement overlap.
Avoid combination due to interaction risks.
Avoid due to incompatibility concerns.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
not approved
UK
approved
EU
approved
Australia
approved
Canada
approved
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 3, 2023